AVXL
NASDAQStockAnavex Life Sciences Corp.
$4.66+0.01 (+0.22%)
52-Week Range
$3.08
$13.41
Key Stats
Market Cap
431.9M
P/E Ratio
—
Dividend Yield
—
Beta
1.05
Volume
819.9K
Avg Volume
1.1M
Performance
1M
+18.62%
3M
+12.32%
6M
-48.82%
YTD
+26.36%
1Y
-50.69%
3Y
-50.32%
5Y
-68.62%
Price Chart
ETF Exposure
AVXL is held by 63 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| IBRN | iShares Neuroscience and Healthcare ETF | 0.55% |
| SBIO | ALPS Medical Breakthroughs ETF | 0.28% |
| CURE.AX | Global X - S&P Biotech ETF | 0.16% |
| XBI | State Street SPDR S&P Biotech ETF | 0.15% |
| IWC | iShares Micro-Cap ETF | 0.08% |
| SMLF | iShares U.S. Small-Cap Equity Factor ETF | 0.04% |
| IBB | iShares Biotechnology ETF | 0.04% |
| LABU | Direxion Daily S&P Biotech Bull 3X ETF | 0.03% |
| PWS | Pacer WealthShield ETF | 0.03% |
| SBIO.L | Invesco NASDAQ Biotech UCITS ETF | 0.03% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.03% |
| STSB | iShares Factors US Small Blend Style ETF | 0.03% |
| IWO | iShares Russell 2000 Growth ETF | 0.03% |
| VTWG | Vanguard Russell 2000 Growth ETF | 0.03% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.02% |
| XRS2.DE | Xtrackers Russell 2000 UCITS ETF 1C | 0.01% |
| XRSU.L | Xtrackers Russell 2000 UCITS ETF 1C | 0.01% |
| SC0K.DE | Invesco Russell 2000 UCITS ETF | 0.01% |
| IWM | iShares Russell 2000 ETF | 0.01% |
| RESM | Columbia Research Enhanced Small Cap ETF | 0.01% |
| VTWO | Vanguard Russell 2000 ETF | 0.01% |
| XSU.TO | iShares U.S. Small Cap Index ETF (CAD-Hedged) | 0.01% |
| RSSL | Global X - Russell 2000 ETF | 0.01% |
| SCHA | Schwab U.S. Small-Cap ETF | 0.01% |
| UWM | ProShares - Ultra Russell2000 | 0.01% |
| URTY | ProShares - UltraPro Russell2000 | 0.01% |
| ISCB | iShares Morningstar Small-Cap ETF | 0.01% |
| ISCG | iShares Morningstar Small-Cap Growth ETF | 0.01% |
| ISCV | iShares Morningstar Small-Cap Value ETF | 0.01% |
| JKJ | iShares Morningstar Small-Cap ETF | 0.01% |
| JKK | iShares Morningstar Small-Cap Growth ETF | 0.01% |
| JKL | iShares Morningstar Small-Cap Value ETF | 0.01% |
| VHT | Vanguard Health Care ETF | 0.01% |
| VXF | Vanguard Extended Market ETF | 0.01% |
| SMMD | iShares Russell 2500 ETF | 0.00% |
| HDG | ProShares - Hedge Replication ETF | 0.00% |
| TILT | FlexShares Morningstar U.S. Market Factor Tilt Index Fund | 0.00% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.00% |
| IWV | iShares Russell 3000 ETF | 0.00% |
| VTHR | Vanguard Russell 3000 ETF | 0.00% |
| VTI | Vanguard Total Stock Market ETF | 0.00% |
| VUN.TO | Vanguard U.S. Total Market Index ETF | 0.00% |
| VUS.TO | Vanguard U.S. Total Market Index ETF (CAD-hedged) | 0.00% |
| DFAC | Dimensional - US Core Equity 2 ETF | 0.00% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.00% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.00% |
Page 1 of 2Next
About AVXL ETF Exposure
Anavex Life Sciences Corp. (AVXL) is held by 63 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 431.9M, AVXL is a widely held institutional stock. The stock currently trades at $4.66. Investors can gain exposure to AVXL through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold AVXL, sorted by portfolio weight.